Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2015

Dec 8, 2015

29841_dirs_2015-12-08_bbbc2b34-9c5f-4cb9-ac22-b123318ec3da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2015-12-04

Reporting Person: Kuntz Richard (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-04 Ordinary Shares M 15401 $48.7 Acquired 121801 Direct
2015-12-04 Ordinary Shares S 13715 $78.0637 Disposed 108086 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-04 Employee Stock Option (right to buy) $48.7 M 15401 Disposed 2016-10-30 Ordinary Shares (15401) Direct

Footnotes

F1: This balance increased by 269 shares due to exempt transactions such as dividend reinvestment.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

F3: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.0500 to $78.0900, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote to this Form 4.